PEREGRINE CAPITAL MANAGEMENT LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,839,525
+98428.4%
301,068
+3.0%
0.05%
-10.2%
Q4 2022$1,867
-99.9%
292,165
+21.0%
0.06%
-21.3%
Q3 2022$2,314,000
-17.7%
241,494
-5.2%
0.08%
-11.8%
Q2 2022$2,813,000
-34.5%
254,812
-1.1%
0.08%
-16.7%
Q1 2022$4,292,000
-10.7%
257,776
+2.4%
0.10%
+6.2%
Q4 2021$4,808,000
-5.3%
251,850
+22.4%
0.10%
-8.6%
Q3 2021$5,076,000
-20.9%
205,834
-16.5%
0.10%
-8.7%
Q2 2021$6,416,000
-14.2%
246,582
+4.4%
0.12%
-17.3%
Q1 2021$7,478,000
-40.1%
236,184
-12.3%
0.14%
-41.4%
Q4 2020$12,492,000
+2.3%
269,229
-27.4%
0.24%
-26.9%
Q3 2020$12,216,000
+9.5%
371,068
-8.7%
0.32%
+2.2%
Q2 2020$11,156,000
-1.8%
406,401
+7.1%
0.32%
-22.1%
Q1 2020$11,358,000
-24.3%
379,418
-30.0%
0.41%
+6.5%
Q4 2019$15,002,000
+28.1%
541,976
-15.8%
0.38%
+19.7%
Q3 2019$11,710,000
-27.4%
643,415
-2.2%
0.32%
-19.8%
Q2 2019$16,126,000
+103.9%
657,651
-20.9%
0.40%
+101.0%
Q1 2019$7,908,000831,5150.20%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders